Reportedly, as blood sclerostin levels increase, BMD decreases in postmenopausal women, and postmenopausal women with significantly increased serum Dkk-1 exhibit more significant osteoporosis [23, 24]. The gene discussed is SOST; the disease is osteoporosis.